Investor profile for New Enterprise Associates (NEA): stage-based planning range, investment stages, sector focus, portfolio companies, sources, and verification status. Part of the Venture Capital Tracker directory.

VC fund profile · evidence-aware directory data

New Enterprise Associates (NEA) stages, portfolio and investment profile

Global multi-stage firm founded in 1977 with a major New York office — investing across technology, healthcare, and life sciences from seed through growth.

Keep track of New Enterprise Associates (NEA)

Save this profile to your VCT watchlist for a quick return.

View watchlist

Stage-based planning range

$1M–$10M

This is a planning range inferred from stage coverage, not a firm-disclosed check size.

Methodology: Stage bucket inferred from the rounds a fund leads or invests in.

No firm-specific check-size disclosure is recorded.

Source link not recorded Confidence: 25% Verified: Not recorded View methodology

Investment stages

Leads: Series A, Series B+

Participates: Seed, Series A, Series B+

Sector focus

biotech-life-sciences · enterprise-saas · healthtech

Geography

900 3rd Ave, New York, NY 10022

Founded 1977

Fund size / AUM

Not recorded

A separate fund-size evidence record is not yet available.

Portfolio in our directory

38

Linked startup profiles

Latest fund vehicle

Not recorded

Vehicle name, size, and vintage are not yet structured.

Recent tracked investment

Not recorded

No dated round explicitly links this fund.

Rounds they lead

Series A Series B+

Rounds they invest

Seed Series A Series B+

Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.

Portfolio companies we track

Startups in our directory that list New Enterprise Associates (NEA) as an investor (24 total).

Related investment articles

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.